Lifegraph Biomedical Instrumentation Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 21.05 K
- Company Age 5 Year, 6 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth -46.58%
- Profit Growth -97.88%
- Ebitda -213.11%
- Net Worth 45.37%
- Total Assets -3.34%
About Lifegraph Biomedical Instrumentation
Lifegraph Biomedical Instrumentation Private Limited (LBIPL) is a registered startup operating as a Private Limited Indian Non-Government Company incorporated in India on 20 August 2019 (Five years and six months 9 days old ). Its registered office is in Buxar, Bihar, India.
The Company is engaged in the Electrnoics Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 21.05 K , as per Ministry of Corporate Affairs (MCA) records.
Sagar Raj and Sourabh Jangid serve as directors at the Company.
Company Details
- Location
Buxar, Bihar, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U29309BR2019PTC043048
- Company No.
043048
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
20 Aug 2019
- Date of AGM
25 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Patna
Industry
Who are the key members and board of directors at Lifegraph Biomedical Instrumentation?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sagar Raj  | Director | 20-Aug-2019 | Current |
| Sourabh Jangid | Director | 08-Nov-2022 | Current |
Financial Performance of Lifegraph Biomedical Instrumentation.
Lifegraph Biomedical Instrumentation Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 46.58% decrease. The company also saw a substantial fall in profitability, with a 97.88% decrease in profit. The company's net worth Soared by an impressive increase of 45.37%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Lifegraph Biomedical Instrumentation?
Unlock access to Lifegraph Biomedical Instrumentation's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Lifegraph Biomedical Instrumentation?
Unlock and access historical data on people associated with Lifegraph Biomedical Instrumentation, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Lifegraph Biomedical Instrumentation, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Lifegraph Biomedical Instrumentation's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
